Haemonetics (HAE) Q3 Earnings Top Estimates, Margin Contracts

HAE - Free Report) delivered adjusted earnings per share (EPS) of 81 cents in the third quarter of fiscal 2021, reflecting a 13.8% year-over-year decline. The bottom line, however, exceeded the Zacks Consensus Estimate by 19.1%. On a GAAP basis, net income was 62 cents per share, up 6.9% from...